Skip to content
Subscriber Only

Takeda Loses First Federal Trial Over Actos Diabetes Drug

Takeda Pharmaceutical Co. lost the first federal court trial in the U.S. over claims it hid the cancer risks of its Actos diabetes medicine to protect billions of dollars in sales.

The jury in Lafayette, Louisiana, today awarded $1.5 million in compensatory damages and will consider a request for punitive damages.